Preconditioning and hypothermic cardioplegia protect human heart equally against ischemia

Annals of Thoracic Surgery

Volumn 63, Issue 1, 1997, Pages 147-152

  Cleveland Jr , Joseph C ^a   Meldrum, Daniel R ^a   Rowland, Robert T ^a   Banerjee, Anirban ^a   Harken, Alden H ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE;

ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; HEART PACING; HEART PROTECTION; HEART RIGHT ATRIUM; HUMAN; HUMAN TISSUE; HYPOTHERMIA; PRIORITY JOURNAL;

CREATINE KINASE; FEMALE; HEART ARREST, INDUCED; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIUM; TEMPERATURE; TIME FACTORS;

EID: 0031036038     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00924-1     Document Type: Article

References (20)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium . Circulation. 74:1986;1124-1136.
2. 1-adrenergic mechanism. Circ Res. 73:1993;656-670.
3. Meldrum DR, Cleveland JC Jr, Sheridan BC, Rowland RT, Banerjee A, Harken AH. Cardiac surgical implications of calcium dyshomeostasis in the heart. Ann Thorac Surg. 61:1996;1273-1280.
4. 1 adenosine receptors in rabbit heart. Circulation. 84:1991;350-356.
5. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res. 66:1990;1133-1142.
6. Cleveland JC Jr, Wollmering M, Meldrum D, et al. Ischemic preconditioning in human and rat ventricle. Am J Physiol. 271:1996;H1786-94.
7. Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DM. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol. 27:1995;1349-1357.
8. + channel? Circ Res. 77:1995;1030-1035.
9. Yellon DM, Alkhulaifi A, Pugsley WB. Preconditioning the human myocardium. Lancet. 342:1993;276-277.
10. Cave AC, Hearse DJ. Ischaemic preconditioning and contractile function studies with normothermic and hypothermic global ischemia . J Mol Cell Cardiol. 24:1992;1113-1123.
11. Hypoxic preconditioning enhances functional recovery after prolonged cardioplegic arrest. Ann Thorac Surg. 59:1995;428-432.
12. Keon WJ, Hendry PJ, Taichman GC, Mainwood GW. Cardiac transplantation the ideal myocardial temperature for graft transport . Ann Thorac Surg. 46:1988;337-341.
13. Banerjee A, Grosso MA, Brown JM, Rogers KB, Whitman GJR. Oxygen metabolite effects on creatine kinase and cardiac energetics after reperfusion. Am J Physiol. 261:1991;H590-7.
14. Deslauriers R, Keon W, Lareau S, et al. Preservation of high energy phosphates in human myocardium. J Thorac Cardiovasc Surg. 98:1989;402-412.
15. Engelman D, Chen C, Watanabe M, et al. Improved 4- and 6-hour myocardial preservation by hypoxic preconditioning. Circulation. 92(Suppl 2):1995;417-422.
16. Davies F, Francis E, Stoner H. The distribution of nucleotide, phosphocreatine, and glycogen in the heart. J Physiol. 106:1947;154-166.
17. Urthaler F, Walker AA, Hefner LL, James TN. Comparison of contractile performance of canine atrial and ventricular muscles. Circ Res. 37:1975;762-771.
18. Schwinger RHG, Bohm M, Koch A, et al. Force-frequency-relation in human atrial and ventricular myocardium. Mol Cell Biochem. 119:1993;73-78.
19. Mekhfi H, Veksler V, Mateo P, Maupoil V, Rochette L, Ventura-Clapier R. Creatine kinase is the main target of reactive oxygen species in cardiac myofibrils. Circ Res. 78:1996;1016-1027.
20. Kida M, Fujiwara H, Ishida M, et al. Ischemic preconditioning preserves creatine phosphate and intracellular pH. Circulation. 84:1991;2495-2503.